David Rosenberg, a leading expert in child and adolescent psychiatry, sheds light on the controversial use of electroconvulsive therapy (ECT) for treating severe depression in teens. He discusses a significant study revealing that ECT can achieve over 70% success rates, highlighting its potential as a last resort for treatment-resistant cases. Rosenberg emphasizes the importance of personalized treatment and the impact of factors like age and co-existing disorders on ECT outcomes. It's a thought-provoking conversation on navigating critical mental health dilemmas.

David Rosenberg, an expert in child and adolescent psychiatry, dives into the intriguing link between gut health and ADHD. He discusses a recent meta-analysis examining the potential role of probiotics in managing ADHD symptoms. While results show limited efficacy when used alone, there are hints of benefits when combined with traditional treatments. This fascinating conversation pushes the boundaries of ADHD research and highlights the need for further exploration into alternative therapies.

David Rosenberg, a leading expert in child and adolescent psychiatry, discusses his groundbreaking observational study on using risperidone to treat anorexia nervosa in young patients. He highlights the urgent need for effective medications in this challenging area. Despite risperidone being well tolerated, the study reveals it did not significantly improve outcomes like weight gain. Rosenberg emphasizes the complexity of treating this disorder and the necessity for further research into long-term effects and alternative solutions.